
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link rel="preconnect" href="https://www.googletagmanager.com">
<link rel="dns-prefetch" href="https://www.google-analytics.com">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Endometrial Cancer - Gynecology and Obstetrics - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "b70abee6-7ee0-4ca4-bbc4-d37298f9a946";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v1066832";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "162d4b90-6d55-41c2-abd3-16c5150e6d23",
 VasontId : "v1066455"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "b0d75e20-e4c1-4752-bca2-5e83c01332e5",
 VasontId : "v878845"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = 'dd1b6990-fbf3-4643-a50a-2ab4fe8af766';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Endometrial Cancer
 </h1>
 <h2 class="topic__section topic__header__headermodify--subtitle">(Uterine Cancer)</h2>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/ramirez-pedro.html">Pedro T. Ramirez</a></strong>
 <p class="topic__authors--description">, MD, Houston Methodist Hospital;</p>
 <br>
 <strong class="topic__label topic__label--author"><a href="./Contributors/salvo-gloria.html">Gloria Salvo</a></strong>
 <p class="topic__authors--description">, MD, MD Anderson Cancer Center</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Sep 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="182.0;198.82;233.2" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v1066846" class="topicmenu_mobile__paragraph">Etiology</a>
 </li>
 <li>
 <a href="#v1066874" class="topicmenu_mobile__paragraph">Pathology</a>
 </li>
 <li>
 <a href="#v1066878" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v1066881" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v1067002" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v1066999" class="topicmenu_mobile__paragraph">Prognosis</a>
 </li>
 <li>
 <a href="#v8544478" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 <li>
 <a href="#v31322697" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Images (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="FIGO Staging of Uterine Corpus Carcinoma and Carcinosarcoma">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 FIGO Staging of Uterine Corpus...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"216003cb-679f-454b-b34f-ff56fe4fd0b7","Title":"FIGO%20Staging%20of%20Uterine%20Corpus%20Carcinoma%20and%20Carcinosarcoma","ShareUrlTitle":"figo-staging-of-uterine-corpus-carcinoma-and-carcinosarcoma","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066908","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"FIGO%20Staging%20of%20Uterine%20Corpus%20Carcinoma%20and%20Carcinosarcoma","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v1066843" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy, bilateral salpingo-oophorectomy, and, for high-risk histology, usually pelvic and para-aortic lymphadenectomy. For advanced cancer, radiation therapy, endocrine therapy, or chemotherapy is usually indicated.</div></p></div><span id="v1066845" class="anchor"></span><div class="para"> <p>Endometrial cancer is more common in high-resource countries where obesity rates are high. In the United States, this cancer is the 4th most common cancer among women. The American Cancer Society estimates that in 2023, approximately 66,200 new cases of endometrial cancer will be diagnosed and that approximately 13,030 women will die of this cancer (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276" data-toggle="tooltip" title="General references" data-id="73d78419-e423-4b33-be39-3a65f053ab6a" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">1</a><span id="73d78419-e423-4b33-be39-3a65f053ab6a" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Approximately 80% of these new cases will be early stage with good prognosis, and the remaining 20% will have high-grade or advanced-stage disease (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276" data-toggle="tooltip" title="General references" data-id="636c98cf-4414-42de-9dbd-a96009901f30" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">2</a><span id="636c98cf-4414-42de-9dbd-a96009901f30" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v84058215" class="anchor"></span><div class="para"> <p>In the United States, endometrial cancer incidence is higher than average in Black, American Indian, and Alaska Native women (Hispanic 26.1/100,000; Non-Hispanic American Indian or Alaska Native 28.8; Non-Hispanic Asian or Pacific Islander 22.7; Non-Hispanic Black 29.4; Non-Hispanic White 27.6) (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276" data-toggle="tooltip" title="General references" data-id="50a1cedc-2c6f-4962-b407-e8c2fc428a58" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">3</a><span id="50a1cedc-2c6f-4962-b407-e8c2fc428a58" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Mortality is highest in Black women (Hispanic 4.3/100,000; Non-Hispanic American Indian or Alaska Native 4.5; Non-Hispanic Asian or Pacific Islander 3.5; Non-Hispanic Black 9.1; Non-Hispanic White 4.6) (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276" data-toggle="tooltip" title="General references" data-id="ef004aae-261d-4ec6-b6cd-9941752d60db" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">3</a><span id="ef004aae-261d-4ec6-b6cd-9941752d60db" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v8544431" class="anchor"></span><div class="para"> <p>Endometrial cancer affects mainly postmenopausal women. Median patient age at diagnosis is 63 years (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276" data-toggle="tooltip" title="General references" data-id="fb333763-a373-475a-89ff-16e37468ab94" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">3</a><span id="fb333763-a373-475a-89ff-16e37468ab94" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v68352276"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Most cases are diagnosed in women aged 55 to 64 years. </p></div> <section id="v68352275" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v68352276" class="anchor"></span> General references </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v68352279" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/endometrial-cancer/about/key-statistics.html">American Cancer Society</a>: Key Statistics for Endometrial Cancer. Accessed July 14, 2023.</p></div></li><li class="topic__listitem"><span id="v84058220" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html">American Cancer Society</a>: Cancer Facts & Figures 2023.Atlanta: American Cancer Society; 2023. Accessed July 14, 2023.</p></div></li><li class="topic__listitem"><span id="v84058223" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://seer.cancer.gov/statfacts/html/corp.html">National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program</a>: Cancer Stat Facts: Uterine Cancer. Accessed July 14, 2023</p></div></li></ul></div> </div> </section> <section id="v1066846" class="topic__section FHead" itemprop="cause" itemscope="" itemtype="http://schema.org/MedicalCause"> <h2 id="Etiology_v1066847" class="topic__header--section" data-originaltitle="Etiology"> <span id="v1066847" class="anchor"></span> Etiology of Endometrial Cancer </h2> <div class="topic__content"> <span id="v1066848" class="anchor"></span><div class="para"> <p>Risk factors for endometrial cancer are</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31322604" class="anchor"></span><div class="para"> <p>Unopposed <span class="genericDrug" data-showrollover="false">estrogen </span>(high serum levels of <span class="genericDrug" data-showrollover="false">estrogen</span> and no or low <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>progesterone</span>) </p></div></li><li class="topic__listitem"><span id="v31322607" class="anchor"></span><div class="para"> <p>Age > 45 years</p></div></li><li class="topic__listitem"><span id="v1066851" class="anchor"></span><div class="para"> <p>Obesity</p></div></li><li class="topic__listitem"><span id="v68352283" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span> use for <span class='symbol'>></span> 2 years</p></div></li><li class="topic__listitem"><span id="v68352285" class="anchor"></span><div class="para"> <p>Lynch syndrome</p></div></li><li class="topic__listitem"><span id="v68352287" class="anchor"></span><div class="para"> <p>Previous pelvic radiation therapy</p></div></li></ul></div><span id="v1066869" class="anchor"></span><div class="para"> <p>Increased exposure to extrinsic or intrinsic <span class="genericDrug" data-showrollover="false">estrogen</span> may be associated with</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v42291228" class="anchor"></span><div class="para"> <p>Obesity</p></div></li><li class="topic__listitem"><span id="v42291230" class="anchor"></span><div class="para"> <p> <a href="./{CB5AADC3-B046-4034-ADA7-BAA2FF62B1A3}.html" data-toggle="tooltip" title="Polycystic Ovary Syndrome (PCOS)" data-id="7af1e185-d52b-48bb-8b66-9a1a421cce62" data-itemid="cb5aadc3-b046-4034-ada7-baa2ff62b1a3">Polycystic ovary syndrome</a><span id="7af1e185-d52b-48bb-8b66-9a1a421cce62" class="d-none xref"> <span class="tooltip-container"> <a href="./{CB5AADC3-B046-4034-ADA7-BAA2FF62B1A3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Polycystic Ovary Syndrome (PCOS) </span> Polycystic ovary syndrome is a clinical syndrome typically characterized by anovulation or oligo-ovulation, signs of androgen excess (eg, hirsutism, acne), and multiple ovarian cysts in the... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/c/o/pcos_02_high_blausen.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Polycystic Ovary Syndrome (PCOS)" loading="lazy"> </span> </a> </span> </span> or other <a href="./{B0E57D90-26C0-41FB-8CF2-41CE3E44578B}.html#v1062287" data-toggle="tooltip" title="Etiology" data-id="588d4334-2cf9-4f68-b6b6-e50ca55510ea" data-itemid="b0e57d90-26c0-41fb-8cf2-41ce3e44578b">ovulatory dysfunction</a><span id="588d4334-2cf9-4f68-b6b6-e50ca55510ea" class="d-none xref"> <span class="tooltip-container"> <a href="./{B0E57D90-26C0-41FB-8CF2-41CE3E44578B}.html#v1062287"> <span class="tooltip-content"> <span class="tooltip-heading"> Etiology </span> Abnormal uterine bleeding (AUB) in patients of reproductive age is a bleeding pattern that is not consistent with normal menstrual cycle parameters (frequency, regularity, duration, and volume)... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v42291241" class="anchor"></span><div class="para"> <p>Estrogen therapy without <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>progesterone</span></p></div></li><li class="topic__listitem"><span id="v42291232" class="anchor"></span><div class="para"> <p>Nulliparity</p></div></li><li class="topic__listitem"><span id="v49777898" class="anchor"></span><div class="para"> <p>Early menarche</p></div></li><li class="topic__listitem"><span id="v42291234" class="anchor"></span><div class="para"> <p>Late menopause</p></div></li><li class="topic__listitem"><span id="v42291236" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Estrogen</span>-producing tumors</p></div></li></ul></div><span id="v31322610" class="anchor"></span><div class="para"> <p>Most endometrial cancers are caused by sporadic mutations. However, in approximately 5% of patients, inherited mutations cause endometrial cancer; endometrial cancer due to inherited mutations tends to occur at a younger age and is often diagnosed 10 to 20 years earlier than sporadic cancer. About half of cases that involve heredity occur in families with <a href="./{068A867A-E1FD-4515-9940-CDB35B9CA0A4}.html" data-toggle="tooltip" title="Lynch Syndrome" data-id="859f8e08-1e7d-46d3-aa6e-c8025443acab" data-itemid="068a867a-e1fd-4515-9940-cdb35b9ca0a4">Lynch syndrome </a><span id="859f8e08-1e7d-46d3-aa6e-c8025443acab" class="d-none xref"> <span class="tooltip-container"> <a href="./{068A867A-E1FD-4515-9940-CDB35B9CA0A4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Lynch Syndrome </span> Lynch syndrome is an autosomal dominant disorder responsible for 2 to 3% of cases of colorectal cancer ( 1). Symptoms, initial diagnosis, and treatment are similar to other forms of colorectal... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>(hereditary nonpolyposis colorectal cancer (HNPCC]). Patients who have Lynch syndrome have a high risk of developing other cancers (eg, <a href="./{F22D0D54-B1B3-42B8-A738-7D7CDF7C5056}.html" data-toggle="tooltip" title="Colorectal Cancer" data-id="41fad22b-f88f-46fd-8b95-7004e7184fe2" data-itemid="f22d0d54-b1b3-42b8-a738-7d7cdf7c5056">colorectal cancer</a><span id="41fad22b-f88f-46fd-8b95-7004e7184fe2" class="d-none xref"> <span class="tooltip-container"> <a href="./{F22D0D54-B1B3-42B8-A738-7D7CDF7C5056}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Colorectal Cancer </span> Colorectal cancer is extremely common. Symptoms include blood in the stool and change in bowel habits. Diagnosis is by colonoscopy. Treatment is surgical resection and chemotherapy for nodal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/2/c0239035-colorectal-cancer-ct-scan-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Colorectal Cancer" loading="lazy"> </span> </a> </span> </span>, <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html" data-toggle="tooltip" title="Ovarian, Fallopian Tube, and Peritoneal Cancer" data-id="7151c73f-1a9c-4f8e-af3a-d4d2493e735a" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">ovarian cancer</a><span id="7151c73f-1a9c-4f8e-af3a-d4d2493e735a" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Ovarian, Fallopian Tube, and Peritoneal Cancer </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v1066874" class="topic__section FHead"> <h2 id="Pathology_v1066875" class="topic__header--section" data-originaltitle="Pathology"> <span id="v1066875" class="anchor"></span> Pathology of Endometrial Cancer </h2> <div class="topic__content"> <span id="v1066876" class="anchor"></span><div class="para"> <p>Endometrial cancer is usually preceded by endometrial hyperplasia. Endometrial carcinoma is commonly classified into 2 types. </p></div><span id="v8544432" class="anchor"></span><div class="para"> <p><b>Type I</b> (non-aggressive) tumors are more common, are usually <span class="genericDrug" data-showrollover="false">estrogen</span>-responsive, and are usually diagnosed in women with obesity and at younger ages (perimenopause or early in menopause). They are preceded by endometrial hyperplasia. These tumors are usually low-grade; the prognosis is good. Endometrioid adenocarcinoma (grades 1 and 2) is the most common histology. These tumors may show microsatellite instability and have mutations in <i data-mmanualobjecttype='gene' '>PTEN</i>, <i data-mmanualobjecttype='gene' '>PIK3CA</i>, <i data-mmanualobjecttype='gene' '>KRAS</i>, and <i data-mmanualobjecttype='gene' '>CTNNB</i>1. </p></div><span id="v8544437" class="anchor"></span><div class="para"> <p><b>Type II</b> (aggressive) tumors are usually high-grade and include grade 3 endometrioid carcinomas and tumors with nonendometrioid histology (eg, serous, clear cell, mixed cell, undifferentiated, mixed, mesonephric-like, gastrointestinal mucinous-type, and carcinosarcoma). They tend to occur in older women. Approximately 10 to 30% have <i data-mmanualobjecttype='gene' '>p53</i> mutations (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058244" data-toggle="tooltip" title="Pathology references" data-id="a4b5e6ad-d9ce-4c05-8047-861d6fd5828e" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">1</a><span id="a4b5e6ad-d9ce-4c05-8047-861d6fd5828e" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058244"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathology references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Up to 10% of endometrial carcinomas are type II (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058244" data-toggle="tooltip" title="Pathology references" data-id="ee8189f2-f567-4964-b54c-453d7935882c" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">2</a><span id="ee8189f2-f567-4964-b54c-453d7935882c" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058244"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathology references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). The prognosis is poor.</p></div><span id="v31322611" class="anchor"></span><div class="para"> <p><b>Endometrioid adenocarcinomas</b> account for approximately 75 to 80% of endometrial cancers (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058244" data-toggle="tooltip" title="Pathology references" data-id="1cdfc3da-d3d6-41f5-971d-157e40065cf0" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">3</a><span id="1cdfc3da-d3d6-41f5-971d-157e40065cf0" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058244"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathology references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v84058231" class="anchor"></span><div class="para"> <p>There are 4 distinct <i>molecular subtypes</i> of endometrioid endometrial carcinomas (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058244" data-toggle="tooltip" title="Pathology references" data-id="6302ec78-8128-4afd-b0f4-7fc0252aa257" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">4</a><span id="6302ec78-8128-4afd-b0f4-7fc0252aa257" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058244"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathology references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>): </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v84058235" class="anchor"></span><div class="para"> <p>POLE ultramutated (<i data-mmanualobjecttype='gene' '>POLEmut</i>): Characterized by pathogenic mutations in the exo nuclease domain of DNA polymerase-ε, resulting in an ultra-high tumor mutational burden and a <i>good prognosis</i></p></div></li><li class="topic__listitem"><span id="v84058237" class="anchor"></span><div class="para"> <p>Mismatch repair-deficient (MMRd): Has loss of mismatch repair proteins, resulting in microsatellite instability and an <i>intermediate prognosis</i></p></div></li><li class="topic__listitem"><span id="v84058241" class="anchor"></span><div class="para"> <p>No specific molecular profile (NSMP): Has no single identifying molecular feature and tumor stage- and grade-dependent outcomes and an <i>intermediate prognosis</i></p></div></li><li class="topic__listitem"><span id="v84058239" class="anchor"></span><div class="para"> <p>p53-mutant: Has a low tumor mutational burden and high somatic copy-number alterations resulting in a <i>poor prognosis</i></p></div></li></ul></div><span id="v84058242" class="anchor"></span><div class="para"> <p>Determining the molecular subtype, if feasible, adds valuable information to the standard clinicopathological risk factors to classify patients with endometrial cancer into risk groups, predict prognosis, and guide treatment recommendations.</p></div><span id="v31322612" class="anchor"></span><div class="para"> <p><b>Uterine papillary serous carcinomas</b> (10%), <b>clear cell carcinomas</b> (< 5%), and <b>carcinosarcomas</b> (< 5%) are considered more aggressive, high-risk histologies and are associated with a higher incidence of extrauterine disease at presentation. Carcinosarcomas used to be categorized as sarcomas but are now considered and treated as high-grade epithelial tumors (carcinomas).</p></div><span id="v49777899" class="anchor"></span><div class="para"> <p><b>Mucinous carcinomas</b> are typically low-grade; the prognosis is good. <i data-mmanualobjecttype='gene' '>KRAS</i> mutations are common in these tumors.</p></div><span id="v68352291" class="anchor"></span><div class="para"> <p>Other histopathologic types of endometrial carcinoma are neuroendocrine, undifferentiated, and mixed carcinoma (composed of more than one type, with at least 10% of each component).</p></div><span id="v1066877" class="anchor"></span><div class="para"> <p>Endometrial cancer may spread as follows:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31322615" class="anchor"></span><div class="para"> <p>From the surface of the uterine cavity to the cervical canal</p></div></li><li class="topic__listitem"><span id="v31322617" class="anchor"></span><div class="para"> <p>Through the myometrium to the serosa and into the peritoneal cavity</p></div></li><li class="topic__listitem"><span id="v31322619" class="anchor"></span><div class="para"> <p>Via the lumen of the fallopian tube to the ovary, broad ligament, and peritoneal surfaces</p></div></li><li class="topic__listitem"><span id="v31322621" class="anchor"></span><div class="para"> <p>Via the bloodstream, leading to distant metastases</p></div></li><li class="topic__listitem"><span id="v31322623" class="anchor"></span><div class="para"> <p>Via the lymphatics</p></div></li></ul></div><span id="v31322624" class="anchor"></span><div class="para"> <p>The higher (more undifferentiated) the grade of the tumor, the greater the likelihood of deep myometrial invasion, pelvic or para-aortic lymph node metastases, or extrauterine spread.</p></div> <section id="v84058243" class="topic__section GHead"> <span></span> <h3 id="Pathology_v1066875_v84058244" class="topic__header--subsection"> <span id="v84058244" class="anchor"></span> Pathology references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84058247" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704730/">Cancer Genome Atlas Research Network, Kandoth C, Schultz N, et al</a>: Integrated genomic characterization of endometrial carcinoma [published correction appears in <i>Nature</i> 2013 Aug 8;500(7461):242]. <i>Nature</i> 497(7447):67-73, 2013. doi:10.1038/nature12113</p></div></li><li class="topic__listitem"><span id="v84058250" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28545689/">Faber MT, Frederiksen K, Jensen A, et al</a>: Time trends in the incidence of hysterectomy-corrected overall, type 1 and type 2 endometrial cancer in Denmark 1978-2014. <i>Gynecol Oncol</i> 146(2):359-367, 2017. doi:10.1016/j.ygyno.2017.05.015</p></div></li><li class="topic__listitem"><span id="v84058253" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/33207095/">Lu KH, Broaddus RR</a>: Endometrial cancer. <i>N Engl J Med</i> 383(21):2053-2064, 2020. doi:10.1056/NEJMra1514010</p></div></li><li class="topic__listitem"><span id="v84058256" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Female-Genital-Tumours-2020">WHO Classification of Tumours Editorial Board</a>: 2020 WHO Classification of Tumours, 5th Edition, Volume 4: Female Genital Tumors. </p></div></li></ul></div> </div> </section> </div> </section> <section id="v1066878" class="topic__section FHead" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <h2 id="SymptomsAndSigns_v1066879" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v1066879" class="anchor"></span> Symptoms and Signs of Endometrial Cancer </h2> <div class="topic__content"> <span id="v1066880" class="anchor"></span><div class="para"> <p>Most (<span class='symbol'>></span> 90%) women with endometrial cancer present with abnormal uterine bleeding (eg, postmenopausal bleeding, premenopausal intermenstrual bleeding, ovulatory dysfunction). Depending on age and risk factors, 6 to 19% of women with postmenopausal bleeding have endometrial cancer (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058260" data-toggle="tooltip" title="Symptoms and signs reference" data-id="1726dcff-d7f5-4189-8136-70faa253fa21" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">1</a><span id="1726dcff-d7f5-4189-8136-70faa253fa21" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058260"> <span class="tooltip-content"> <span class="tooltip-heading"> Symptoms and signs reference </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> <section id="v84058259" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"></span> <h3 id="SymptomsAndSigns_v1066879_v84058260" class="topic__header--subsection"> <span itemprop="name" id="v84058260" class="anchor"></span> Symptoms and signs reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84058263" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142981/">Clarke MA, Long BJ, Del Mar Morillo A, et al</a>: Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. <i>JAMA Intern Med</i> 178(9):1210-1222, 2018. doi:10.1001/jamainternmed.2018.2820</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1066881" class="topic__section FHead"> <h2 id="Diagnosis_v1066882" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v1066882" class="anchor"></span> Diagnosis of Endometrial Cancer </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066886" class="anchor"></span><div class="para"> <p>Endometrial biopsy</p></div></li></ul></div><span id="v1066889" class="anchor"></span><div class="para"> <p>The following suggest endometrial cancer:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066892" class="anchor"></span><div class="para"> <p>Postmenopausal bleeding</p></div></li><li class="topic__listitem"><span id="v1066894" class="anchor"></span><div class="para"> <p>Abnormal bleeding in premenopausal women (intermenstrual bleeding, ovulatory dysfunction), particularly in women > 45 years</p></div></li><li class="topic__listitem"><span id="v1066896" class="anchor"></span><div class="para"> <p>A routine Papanicolaou (Pap) test showing endometrial cells in postmenopausal women</p></div></li><li class="topic__listitem"><span id="v1066898" class="anchor"></span><div class="para"> <p>A routine Pap test showing atypical endometrial cells in any woman</p></div></li></ul></div><span id="v1066899" class="anchor"></span><div class="para"> <p>If endometrial cancer is suspected, outpatient endometrial biopsy is done; sensitivity is <span class='symbol'>></span> 90%. An alternative for average-risk postmenopausal women is transvaginal ultrasonography; biopsy is required if endometrial lining thickness is <span class='symbol'>></span> 4 mm and results are inconclusive (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302" data-toggle="tooltip" title="Diagnosis references" data-id="63fd941d-266e-4313-bb2c-c4d345b25af3" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">1</a><span id="63fd941d-266e-4313-bb2c-c4d345b25af3" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v42291244" class="anchor"></span><div class="para"> <p>If biopsy results are inconclusive or suggest precancer (eg, complex hyperplasia with atypia) or cancer, dilation and curettage (D & C), often with hysteroscopy, is done.</p></div><span id="v1066900" class="anchor"></span><div class="para"> <p>Once endometrial cancer is diagnosed, pretreatment evaluation includes a complete blood count (CBC) and other blood tests (serum electrolytes, kidney, and liver). A chest x-ray is done. If an abnormality is seen on chest x-ray, CT should be done. The following should be considered:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v68352296" class="anchor"></span><div class="para"> <p>Pelvic MRI to determine the origin of the tumor (cervix or uterus) and local extension</p></div></li><li class="topic__listitem"><span id="v68352298" class="anchor"></span><div class="para"> <p>For high-grade carcinomas, chest, abdomen, and pelvic CT</p></div></li><li class="topic__listitem"><span id="v68352300" class="anchor"></span><div class="para"> <p>If metastatic disease is suspected based on physical examination or blood tests, positive emission tomography (PET)-CT</p></div></li></ul></div><span id="v31322625" class="anchor"></span><div class="para"> <p>Because endometrial cancer sometimes results from an inherited mutation, genetic counseling and/or testing should be considered if patients are < 50 years or have a significant family history of endometrial cancer, ovarian cancer, or colorectal cancer or known Lynch syndrome (HNPCC).</p></div> <section id="v1066901" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1066882_v1066902" class="topic__header--subsection"> <span id="v1066902" class="anchor"></span> Staging </h3> <div class="topic__content"> <span id="v1066903" class="anchor"></span><div class="para"> <p>Staging of endometrial cancer is based on non-aggressive versus aggressive histology; extent of spread, including invasion depth, extension to surrounding structures, and extrauterine or lymph node metastases; lymphovascular space invasion; and molecular classification (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"216003cb-679f-454b-b34f-ff56fe4fd0b7","Title":"FIGO%20Staging%20of%20Uterine%20Corpus%20Carcinoma%20and%20Carcinosarcoma","ShareUrlTitle":"figo-staging-of-uterine-corpus-carcinoma-and-carcinosarcoma","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066908","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EFIGO%20Staging%20of%20Uterine%20Corpus%20Carcinoma%20and%20Carcinosarcoma%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). </p></div><span id="v31322627" class="anchor"></span><div class="para"> <p>Staging is surgical and includes exploration of the abdomen and pelvis, biopsy or excision of suspicious extrauterine lesions, total abdominal hysterectomy, and, in patients with high-risk features (grade 1 or 2 cancer plus deep myometrial invasion, grade 3 cancer, all cancers with high-risk histology), pelvic and para-aortic lymphadenectomy. Staging can be done via laparotomy, laparoscopy, or robotic-assisted surgery. If cancer appears to be confined to the uterus, an alternative to pelvic and para-aortic lymphadenectomy is sentinel lymph node mapping.</p></div> <span id="v1066905"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1066910"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"216003cb-679f-454b-b34f-ff56fe4fd0b7","Title":"FIGO%20Staging%20of%20Uterine%20Corpus%20Carcinoma%20and%20Carcinosarcoma","ShareUrlTitle":"figo-staging-of-uterine-corpus-carcinoma-and-carcinosarcoma","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066908","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"FIGO%20Staging%20of%20Uterine%20Corpus%20Carcinoma%20and%20Carcinosarcoma","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="216003cb-679f-454b-b34f-ff56fe4fd0b7"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '216003cb-679f-454b-b34f-ff56fe4fd0b7' }, async: true, success: function (data) { $('#216003cb-679f-454b-b34f-ff56fe4fd0b7').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v84150131" class="anchor"></span><div class="para"> <p>When the molecular classification is known:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v84150201" class="anchor"></span><div class="para"> <p>FIGO Stages I and II are based on surgical/anatomical and histologic findings. For <i data-mmanualobjecttype='gene' '>POLEmut</i> or p53abn status, the FIGO stage is modified in the early stage of the disease. This is depicted in the FIGO stage by the addition of “m” for molecular classification, and a subscript is added to denote <i data-mmanualobjecttype='gene' '>POLEmut</i> or p53abn status. MMRd or NSMP status do not modify early FIGO stages; however, these molecular classifications should be recorded for the purpose of data collection. When molecular classification reveals MMRd or NSMP, it should be recorded as Stage Im or Stage Im and Stage IIm or Stage IIm.</p></div></li><li class="topic__listitem"><span id="v84150203" class="anchor"></span><div class="para"> <p>FIGO Stages III and IV are based on surgical/anatomical findings. The stage category is not modified by molecular classification; however, the molecular classification should be recorded if known, as Stage IIIm or Stage IVm with the appropriate subscript for the purpose of data collection. For example, when molecular classification reveals p53abn, it should be recorded as Stage IIIm or Stage IVm.</p></div></li></ul></div> </div> </section> <section id="v42291275" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1066882_v42291276" class="topic__header--subsection"> <span id="v42291276" class="anchor"></span> Sentinel lymph node mapping in endometrial cancer </h3> <div class="topic__content"> <span id="v42291277" class="anchor"></span><div class="para"> <p>Sentinel lymph node (SLN) mapping can be considered for the surgical staging of cancer that appears confined to the uterus—stage I (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302" data-toggle="tooltip" title="Diagnosis references" data-id="d790fc11-f2a5-43bf-80fd-cd2e34bb25e7" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">2</a><span id="d790fc11-f2a5-43bf-80fd-cd2e34bb25e7" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). In many centers, SLN mapping is currently the standard for cancers with high-risk histology—ie, papillary serous carcinoma, clear cell carcinoma, and carcinosarcoma (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302" data-toggle="tooltip" title="Diagnosis references" data-id="7c007d37-f517-4e22-9a8f-84553e12207c" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">3</a><span id="7c007d37-f517-4e22-9a8f-84553e12207c" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v42291278" class="anchor"></span><div class="para"> <p>The role of SLN mapping in endometrial cancer has been evaluated in several studies. The FIRES trial showed that in patients with clinical stage I endometrial cancer, SLN mapping with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>indocyanine green</span> (ICG) is highly accurate for the diagnosis of endometrial cancer metastases; it was recommended as a replacement for complete lymphadenectomy (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302" data-toggle="tooltip" title="Diagnosis references" data-id="8643fa57-c79c-495e-a378-f932732324b3" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">4</a><span id="8643fa57-c79c-495e-a378-f932732324b3" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). SLN mapping is done as for <a href="./{09EE5CCD-A2D1-40E5-B791-B34C3233F3C4}.html" data-toggle="tooltip" title="Cervical Cancer" data-id="3584846e-302b-428c-9ade-330e0e3ee87d" data-itemid="09ee5ccd-a2d1-40e5-b791-b34c3233f3c4">cervical cancer</a><span id="3584846e-302b-428c-9ade-330e0e3ee87d" class="d-none xref"> <span class="tooltip-container"> <a href="./{09EE5CCD-A2D1-40E5-B791-B34C3233F3C4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Cervical Cancer </span> Cervical cancer is usually squamous cell carcinoma; adenocarcinoma is less common. The cause of most cervical cancers is human papillomavirus (HPV) infection. Cervical neoplasia is often asymptomatic... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/8/5/m8500180-cervical-cancer-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Cervical Cancer" loading="lazy"> </span> </a> </span> </span> using the same tracers (blue dye, technetium-99 [<sup>99</sup>Tc] ICG). Sentinel lymph node mapping can be performed via open or minimally invasive surgery, such as robotic-assisted surgery or laparoscopy (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302" data-toggle="tooltip" title="Diagnosis references" data-id="de41333a-83c4-4ee7-843d-009d33e5b326" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">5</a><span id="de41333a-83c4-4ee7-843d-009d33e5b326" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v42291281" class="anchor"></span><div class="para"> <p>Where to inject the tracer in patients with endometrial carcinoma has been controversial. Evidence suggests that in endometrial cancer, cervical injection with ICG results in a higher detection rate than hysteroscopic injection, and anatomic nodal distribution is similar (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302" data-toggle="tooltip" title="Diagnosis references" data-id="e5fd3eb1-0673-4958-95b9-08ad5b206a84" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">6</a><span id="e5fd3eb1-0673-4958-95b9-08ad5b206a84" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Dye is usually injected into the cervix both superficially (1 to 3 mm) and deep (1 to 2 cm) at 3 and 9 o’clock. With this technique, dye penetrates to the uterine lymphatic trunks (which meet in the parametria) and appears in the broad ligament leading to pelvic and occasionally para-aortic SLNs.</p></div><span id="v42291283" class="anchor"></span><div class="para"> <p>If sentinel lymph nodes are identified bilaterally, no lymphadenectomy is indicated, regardless of tumor characteristics. If one side (or both) has no identified sentinel node, complete lymphadenectomy is necessary on that side. Whether dissection of the para-aortic nodes is necessary is left up to surgeon discretion. </p></div><span id="v42291284" class="anchor"></span><div class="para"> <p>The most common locations of pelvic SLNs are</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v42291287" class="anchor"></span><div class="para"> <p>Medial to the external iliac blood vessels</p></div></li><li class="topic__listitem"><span id="v42291289" class="anchor"></span><div class="para"> <p>Ventral to the internal iliac blood vessels</p></div></li><li class="topic__listitem"><span id="v42291291" class="anchor"></span><div class="para"> <p>In the superior part of the obturator region</p></div></li></ul></div><span id="v42291292" class="anchor"></span><div class="para"> <p>Less common locations are the iliac and/or presacral regions.</p></div><span id="v42291293" class="anchor"></span><div class="para"> <p>A complete pelvic lymphadenectomy should be done when any of the following occur: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v42291296" class="anchor"></span><div class="para"> <p>Mapping does not detect any SLNs in patients with high-risk tumors.</p></div></li><li class="topic__listitem"><span id="v42291298" class="anchor"></span><div class="para"> <p>A hemipelvis cannot be mapped.</p></div></li><li class="topic__listitem"><span id="v42291300" class="anchor"></span><div class="para"> <p>There are any suspicious or grossly enlarged nodes, regardless of mapping.</p></div></li></ul></div><span id="v84058266" class="anchor"></span><div class="para"> <p>An ongoing phase III randomized trial (ENDO-3) is evaluating SLN biopsy with no retroperitoneal node dissection compared with no nodal dissection in clinical stage 1 FIGO grade 1 to 3 endometrioid, clear cell, serous, or carcinosarcoma (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302" data-toggle="tooltip" title="Diagnosis references" data-id="c24b39d1-6639-444a-a030-5888d3d6be78" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">7</a><span id="c24b39d1-6639-444a-a030-5888d3d6be78" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291302"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v42291301" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1066882_v42291302" class="topic__header--subsection"> <span id="v42291302" class="anchor"></span> Diagnosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v68352316" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/29683909/">ACOG (American College of Obstetricians and Gynecologists) Committee Opinion No. 734</a>: The role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding. <i>Obstet Gynecol</i> 131 (5):e124-e129, 2018. doi: 10.1097/AOG.0000000000002631</p></div></li><li class="topic__listitem"><span id="v68352324" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://jamanetwork.com/journals/jamasurgery/fullarticle/2772854">Cusimano MC, Vicus D, Pulman K, et al</a>: Assessment of sentinel lymph node Biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging. <i>JAMA Surg</i> 156 (2):157–164, 2021. doi: 10.1001/jamasurg.2020.5060</p></div></li><li class="topic__listitem"><span id="v68352328" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://europepmc.org/article/MED/31776037">Schlappe BA, Weaver AL, McGree ME, et al</a>: Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma. <i>Gynecol Oncol</i> 156 (1):62–69, 2020. doi: 10.1016/j.ygyno.2019.11.002 </p></div></li><li class="topic__listitem"><span id="v42291305" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(17)30068-2/fulltext">Rossi EC, Kowalski LD, Scalici J, et al</a>: A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): A multicentre, prospective, cohort study. <i>Lancet Oncol</i> 18 (3):384–392, 2017. doi: 10.1016/S1470-2045(17)30068-2</p></div></li><li class="topic__listitem"><span id="v68352332" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://journals.lww.com/greenjournal/Abstract/2021/12000/Minimally_Invasive_Compared_With_Open_Hysterectomy.2.aspx">Segarra-Vidal B, Dinoi G, Zorrilla-Vaca A, et al</a>: Minimally invasive compared with open hysterectomy in high-risk endometrial cancer. <i>Obstet Gynecol</i> 138 (6):828–837, 2021. doi: 10.1097/AOG.0000000000004606</p></div></li><li class="topic__listitem"><span id="v42291309" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://ijgc.bmj.com/content/23/9/1704.long">Rossi EC, Jackson A, Ivanova A, Boggess JF</a>: Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection. <i>Int J Gynecol Cancer</i> 23 (9):1704–1711, 2013. doi: 10.1097/IGC.0b013e3182a616f6</p></div></li><li class="topic__listitem"><span id="v84058269" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34728527/">Obermair A, Nicklin J, Gebski V, et al</a>: A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer - ENDO-3: ANZGOG trial 1911/2020. <i>Int J Gynecol Cancer</i> 31(12):1595-1601, 2021. doi:10.1136/ijgc-2021-003029</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1067002" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v1067003" class="topic__header--section" data-originaltitle="Treatment"> <span id="v1067003" class="anchor"></span> Treatment of Endometrial Cancer </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1067007" class="anchor"></span><div class="para"> <p>Total hysterectomy and bilateral salpingo-oophorectomy</p></div></li><li class="topic__listitem"><span id="v1067009" class="anchor"></span><div class="para"> <p>Pelvic and para-aortic lymphadenectomy for grade 1 or 2 with deep (> 50%) myometrial invasion, any grade 3, and for all cancers with high-risk histology</p></div></li><li class="topic__listitem"><span id="v1067011" class="anchor"></span><div class="para"> <p>Pelvic radiation therapy with or without chemotherapy for stage II or III</p></div></li><li class="topic__listitem"><span id="v1067013" class="anchor"></span><div class="para"> <p>Multimodal therapy usually recommended for stage IV</p></div></li></ul></div><span id="v49777931" class="anchor"></span><div class="para"> <p>(See also <a rel="nofollow" target="_blank" href="https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf">National Comprehensive Cancer Network (NCCN)</a>: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms.)</p></div><span id="v49777933" class="anchor"></span><div class="para"> <p>Endometrial cancer should be removed en bloc, usually by doing a total hysterectomy and bilateral salpingo-oophorectomy. Intraperitoneal tumor fragmentation or morcellation must be avoided.</p></div><span id="v49777934" class="anchor"></span><div class="para"> <p>Surgery can be done by any route (vaginal, open, robotic, laparoscopic). For patients with tumors confined to the uterus, minimally invasive surgery is the preferred approach because its rate of perioperative and postoperative complications is lower, hospital stays are shorter (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="23c21e66-3f96-43e2-82dd-64ac3a223c48" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">1</a><span id="23c21e66-3f96-43e2-82dd-64ac3a223c48" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), cost is lower, and oncologic outcomes are comparable (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="30f2147b-a7db-4de1-877f-fa7a671676d8" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">2</a><span id="30f2147b-a7db-4de1-877f-fa7a671676d8" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v49777937" class="anchor"></span><div class="para"> <p>Evidence generally supports comparable oncologic outcomes for laparoscopic surgery and laparotomy. In the Gynecologic Oncology Group LAP2 study, women with clinical stage I to IIA uterine cancer were randomly assigned to have laparoscopic surgery or laparotomy in a 2 to 1 ratio. The study did not demonstrate the statistical noninferiority of the laparoscopic approach. However, after a median follow-up time of 59 months, survival rates for both approaches were similar; 5-year overall survival rate was 90% in both groups. Estimated 5-year recurrence rates were also similar (14% versus 12% [ <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="d3cf4219-dce6-427d-b0bd-dec229d573fb" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">3</a><span id="d3cf4219-dce6-427d-b0bd-dec229d573fb" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>]). The Laparoscopic Approach to Cancer of the Endometrium (LACE) trial was a prospective, international, randomized trial that included 760 patients with stage I endometrioid uterine cancer. They were randomly assigned to have laparoscopic hysterectomy or open hysterectomy. Disease-free survival at 4.5 years (82% versus 81%) and overall survival (mortality: 7.4% versus 6.8%) were similar (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="1099e023-b189-4857-9478-c98a1c086491" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">4</a><span id="1099e023-b189-4857-9478-c98a1c086491" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v1067014" class="anchor"></span><div class="para"> <p>In patients with <b>grade 1 or 2 endometrial cancer and <span class='symbol'>&lt</span> 50% invasion,</b> the probability of lymph node metastasis is <span class='symbol'>&lt</span> 2% (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="26be5dcb-544f-4cf5-9b05-39df4ef01682" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">5</a><span id="26be5dcb-544f-4cf5-9b05-39df4ef01682" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). In these patients, treatment is usually total hysterectomy and bilateral salpingo-oophorectomy via laparotomy, laparoscopy, or robotic-assisted surgery. However, for young women with stage IA or IB endometrioid adenocarcinoma, ovarian preservation is usually safe and recommended to preserve ovarian function.</p></div><span id="v1067017" class="anchor"></span><div class="para"> <p>If patients have any of the following, pelvic and para-aortic lymphadenectomy is also done (unless <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291276" data-toggle="tooltip" title="Sentinel lymph node mapping in endometrial cancer" data-id="e4d8c6cf-a611-457a-8b0f-c8cd7d3f409d" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">SLN mapping</a><span id="e4d8c6cf-a611-457a-8b0f-c8cd7d3f409d" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291276"> <span class="tooltip-content"> <span class="tooltip-heading"> Sentinel lymph node mapping in endometrial cancer </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> identified bilateral SLNs):</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31322633" class="anchor"></span><div class="para"> <p>Grade 1 or 2 cancer with deep (> 50%) myometrial invasion</p></div></li><li class="topic__listitem"><span id="v31322635" class="anchor"></span><div class="para"> <p>Any grade 3 cancer</p></div></li><li class="topic__listitem"><span id="v31322637" class="anchor"></span><div class="para"> <p>All cancers with high-risk histology (papillary serous carcinoma, clear cell carcinoma, carcinosarcoma)</p></div></li><li class="topic__listitem"><span id="v49777942" class="anchor"></span><div class="para"> <p>Any suspicious or grossly enlarged nodes, regardless of mapping</p></div></li></ul></div><span id="v49777943" class="anchor"></span><div class="para"> <p>If SLNs are identified bilaterally, no lymphadenectomy is indicated, regardless of tumor characteristics. If a sentinel node is not identified on one side, complete lymphadenectomy is necessary on that side.</p></div><span id="v1067018" class="anchor"></span><div class="para"> <p><b>Stage II or III endometrial cancer</b> requires pelvic radiation therapy with or without chemotherapy. Treatment of stage III cancer must be individualized, but surgery is an option; generally, patients who have combined surgery and radiation therapy have a better prognosis. Except in patients with bulky parametrial disease, a total abdominal hysterectomy and bilateral salpingo-oophorectomy should be done.</p></div><span id="v1067019" class="anchor"></span><div class="para"> <p>Treatment of <b>stage IV endometrial cancer</b> is variable and patient-dependent but typically involves a combination of surgery, radiation therapy, and chemotherapy. Occasionally, endocrine therapy should also be considered.</p></div><span id="v1067020" class="anchor"></span><div class="para"> <p>Treatment of stage IV endometrial cancer is variable and patient-dependent but typically involves a combination of surgery, radiation therapy, and chemotherapy. Occasionally, endocrine therapy should also be considered (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="45aad600-1685-4fd6-8dc0-69d0d2c5d2df" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">6</a><span id="45aad600-1685-4fd6-8dc0-69d0d2c5d2df" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v1067023" class="anchor"></span><div class="para"> <p>Several cytotoxic drugs (particularly <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span>) are effective. They are given mainly to women with metastatic or recurrent cancer. Another option is <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxorubicin</span>.</p></div><span id="v49777944" class="anchor"></span><div class="para"> <p>For advanced cancer, chemotherapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> has been the standard. However, recent data support the use of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>lenvatinib</span>, a multitargeted tyrosine kinase inhibitor of VEGF (vascular endothelial growth factor) receptors, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pembrolizumab</span>, a monoclonal antibody that inhibits programmed cell death-1 (PD-1) activity. A recent phase II trial showed an objective response rate of 39.6% in patients taking this combination (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="42baca6e-6980-4fa0-8606-ee6bcf70be12" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">7</a><span id="42baca6e-6980-4fa0-8606-ee6bcf70be12" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> <section id="v49777946" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1067003_v49777947" class="topic__header--subsection"> <span id="v49777947" class="anchor"></span> Advanced or recurrent cancer </h3> <div class="topic__content"> <span id="v49777948" class="anchor"></span><div class="para"> <p>Several studies have shown a benefit for more targeted therapy for recurrent cancer as an alternative to standard chemotherapy (usually <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span>). In a phase II trial of patients with recurrent endometrial cancer, the combination of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>everolimus</span> (an mTOR inhibitor) and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>letrozole</span> (an aromatase inhibitor) showed a clinical benefit rate of 40% and an objective response rate of 32% (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="aa50877b-b417-431b-aa97-83b76bd68b0f" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">8</a><span id="aa50877b-b417-431b-aa97-83b76bd68b0f" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v49777950" class="anchor"></span><div class="para"> <p>In patients with recurrent uterine papillary serous carcinoma, standard chemotherapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> has been the routine recommendation. However, recent data from a prospective phase II trial suggest that adding <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span> provides further benefit. In this trial, patients who had uterine serous carcinoma and who tested positive for human epidermal growth factor receptor 2 (HER2)/neu were randomized to either <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> (control arm) for 6 cycles or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> plus IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span> (experimental arm). The addition of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span> increased progression-free survival from 8 months to 12.6 months (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="12ef6196-4f8d-499f-b5cb-53fe1bef3341" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">9</a><span id="12ef6196-4f8d-499f-b5cb-53fe1bef3341" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v84058273" class="anchor"></span><div class="para"> <p>The combination of chemotherapy and immunotherapy has shown synergistic effects in endometrial cancer treatment. In a phase III global randomized double-blind placebo-controlled trial, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dostarlimab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span>–<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> compared with placebo plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span>–<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> significantly increased progression-free survival (PFS) among patients with advanced (stage III or IV) or recurrent endometrial cancer (PFS at 24 months was 36.1% in the <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dostarlimab</span> group versus 18.1% in the placebo group; hazard ratio, 0.64) (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="ef3ac195-762d-4068-901b-bd1cf6f06066" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">10</a><span id="ef3ac195-762d-4068-901b-bd1cf6f06066" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Overall survival (OS) at 24 months was 71.3% with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dostarlimab</span> and 56.0% with placebo (hazard ratio for mortality, 0.64). Subgroup analysis showed a substantial benefit in patients with high microsatellite instability/mismatch repair-deficient tumors (PFS at 24 months was 61.4% in the <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dostarlimab</span> group versus 15.7% in the placebo group; hazard ratio for progression or death, 0.28).</p></div><span id="v84058275" class="anchor"></span><div class="para"> <p>Adding <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pembrolizumab</span> to chemotherapy appears to provide additional PFS benefit for patients with advanced or recurrent endometrial cancer. A phase III randomized double-blind placebo-controlled trial in patients with stage III-IVB mismatch repair-deficient endometrial cancer treated with chemotherapy (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span>) with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pembrolizumab</span> compared with chemotherapy with placebo found increased PFS in the <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pembrolizumab</span> group (PFS 74% versus 38%; 13.1 versus 8.7 months; hazard ratio, 0.54) (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="9c185bb8-9f00-4097-86ca-862e4bdc58e1" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">11</a><span id="9c185bb8-9f00-4097-86ca-862e4bdc58e1" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v31322662" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1067003_v31322663" class="topic__header--subsection"> <span id="v31322663" class="anchor"></span> Fertility preservation in endometrial hyperplasia and early endometrial cancer </h3> <div class="topic__content"> <span id="v31322664" class="anchor"></span><div class="para"> <p>Patients with complex endometrial hyperplasia and atypia have up to a 50% risk of having concurrent endometrial cancer. Treatment of endometrial hyperplasia consists of progestins or definitive surgery, depending on the complexity of the lesion and the patient’s desire to preserve fertility.</p></div><span id="v31322665" class="anchor"></span><div class="para"> <p>If young patients with grade 1 tumors and no myometrial invasion (documented by MRI) wish to preserve fertility, progestin alone is an option. approximately 46 to 80% of patients have a complete response within 3 months of initiation of therapy. After 3 months, patients should be evaluated via dilation and curettage (D & C) rather than endometrial biopsy.</p></div><span id="v31322666" class="anchor"></span><div class="para"> <p>Alternatively, use of a <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levonorgestrel</span>-releasing intrauterine device (IUD) is being increasingly used to treat patients with complex atypical hyperplasia or grade 1 endometrial cancer. In a prospective, single-arm trial, the 12-month pathologic response rate was 90.6% for complex atypical hyperplasia and 66.7% for grade 1 endometrioid endometrial cancer. Adverse events were mild, and treatment had no negative effects on quality of life (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313" data-toggle="tooltip" title="Treatment references" data-id="e22fb865-6ac0-49dc-bf7f-5f53ad20284c" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">12</a><span id="e22fb865-6ac0-49dc-bf7f-5f53ad20284c" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v42291313"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v31322667" class="anchor"></span><div class="para"> <p>Surgery is recommended if conservative treatment is not effective (endometrial cancer is still present after 6 to 9 months of treatment) or if patients have completed childbearing. Fertility-sparing treatment is contraindicated in patients with high-grade endometrioid adenocarcinomas, uterine papillary serous carcinoma, clear cell carcinoma, or carcinosarcoma.</p></div><span id="v31322668" class="anchor"></span><div class="para"> <p>In young women with stage IA or IB endometrioid adenocarcinoma, ovarian preservation is safe and recommended.</p></div> </div> </section> <section id="v31322672" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1067003_v31322673" class="topic__header--subsection"> <span id="v31322673" class="anchor"></span> High-risk histologies </h3> <div class="topic__content"> <span id="v31322674" class="anchor"></span><div class="para"> <p>Uterine papillary serous carcinoma, clear cell carcinomas, and carcinosarcomas are considered histologically aggressive, high-risk cancers and are thus more likely to have spread outside the uterus at presentation.</p></div><span id="v31322675" class="anchor"></span><div class="para"> <p>Multimodality therapy is typically recommended for these histologically aggressive endometrial tumors. Primary treatment includes abdominal hysterectomy, bilateral salpingo-oophorectomy with pelvic and para-aortic lymphadenectomy, and omental and peritoneal biopsies.</p></div><span id="v31322676" class="anchor"></span><div class="para"> <p>In patients with gross extrauterine disease, cytoreduction should be done to reduce the bulk of the tumor to no gross residual disease.</p></div><span id="v31322677" class="anchor"></span><div class="para"> <p>Adjuvant therapy for papillary serous and clear cell carcinomas depends on the stage: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31322680" class="anchor"></span><div class="para"> <p>Stage IA without myometrial invasion and without residual disease in the hysterectomy specimen: Observation and close follow-up (an acceptable approach)</p></div></li><li class="topic__listitem"><span id="v31322682" class="anchor"></span><div class="para"> <p>Other stage IA and IB or stage II cancers: Usually vaginal brachytherapy followed by systemic chemotherapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span></p></div></li><li class="topic__listitem"><span id="v31322684" class="anchor"></span><div class="para"> <p>More advanced disease: Standard chemotherapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span></p></div></li></ul></div><span id="v31322685" class="anchor"></span><div class="para"> <p>Adjuvant therapy for carcinosarcoma also depends on the stage:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31322688" class="anchor"></span><div class="para"> <p>Stage IA without myometrial invasion and without residual disease in the hysterectomy specimen: Observation and close follow-up (an acceptable approach)</p></div></li><li class="topic__listitem"><span id="v31322690" class="anchor"></span><div class="para"> <p>All other stages: Usually systemic chemotherapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ifosfamide</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span></p></div></li></ul></div> </div> </section> <section id="v42291312" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v1067003_v42291313" class="topic__header--subsection"> <span itemprop="name" id="v42291313" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v49777953" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773219/">Walker JL, Piedmonte MR, Spirtos NM, et al</a>: Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. <i>Clin Oncol</i> 27 (32):5331-5336, 2009. doi: 10.1200/JCO.2009.22.3248 </p></div></li><li class="topic__listitem"><span id="v49777957" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006655.pub3/full">Galaal K, Donkers H, Bryant A, Lopes AD</a>: Laparoscopy versus laparotomy for the management of early stage endometrial cancer. <i>Cochrane Database Syst Rev</i> 10 (10):CD006655, 2018. doi: 10.1002/14651858.CD006655.pub3</p></div></li><li class="topic__listitem"><span id="v49777961" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://ascopubs.org/doi/full/10.1200/JCO.2011.38.8645?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&">Walker JL, Piedmonte MR, Spirtos NM, et al</a>: Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. <i>J Clin Oncol</i> 30 (7):695–700, 2012. doi: 10.1200/JCO.2011.38.8645 </p></div></li><li class="topic__listitem"><span id="v49777965" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://jamanetwork.com/journals/jama/fullarticle/2613158">Janda M, Gebski V, Davies LC, et al</a>: Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: A randomized clinical trial. <i>JAMA</i> 317 (12):1224-1233, 2017. doi: 10.1001/jama.2017.2068</p></div></li><li class="topic__listitem"><span id="v84058278" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381544/">Kumar S, Podratz KC, Bakkum-Gamez JN, et al</a>: Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. <i>Gynecol Oncol</i> 132(1):38-43, 2014. doi:10.1016/j.ygyno.2013.10.002</p></div></li><li class="topic__listitem"><span id="v84058281" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/17442022/">Decruze SB, Green JA</a>: Hormone therapy in advanced and recurrent endometrial cancer: a systematic review. <i>Int J Gynecol Cancer</i> 17(5):964-978, 2007. doi:10.1111/j.1525-1438.2007.00897.x</p></div></li><li class="topic__listitem"><span id="v49777969" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext">Makker V, Rasco D, Vogelzang NJ, et al</a>: <span class="genericDrug" data-showrollover="false">Lenvatinib</span> plus <span class="genericDrug" data-showrollover="false">pembrolizumab</span> in patients with advanced endometrial cancer: An interim analysis of a multicentre, open-label, single-arm, phase 2 trial. <i>Lancet Oncol</i> 20 (5):711–718, 2019. doi: 10.1016/S1470-2045(19)30020-8 </p></div></li><li class="topic__listitem"><span id="v49777973" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Slomovitz BM, Jiang Y, Yates MS, et al</a>: Phase II study of <span class="genericDrug" data-showrollover="false">everolimus</span> and <span class="genericDrug" data-showrollover="false">letrozole</span> in patients with recurrent endometrial carcinoma.<i> J Clin Oncol</i> 33 (8):930–936, 2015. doi: 10.1200/JCO.2014.58.3401</p></div></li><li class="topic__listitem"><span id="v49777977" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Fader AN, Roque DM, Siegel E, et al</a>: Randomized phase II trial of <span class="genericDrug" data-showrollover="false">carboplatin-paclitaxel</span> versus <span class="genericDrug" data-showrollover="false">carboplatin-paclitaxel-trastuzumab</span> in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2/neu. <i>J Clin Oncol</i> 36 (20):2044–2051, 2018. doi: 10.1200/JCO.2017.76.5966</p></div></li><li class="topic__listitem"><span id="v84058290" class="anchor"></span><div class="para"> <p>10. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36972026/">Mirza MR, Chase DM, Slomovitz BM, et al</a>: <span class="genericDrug" data-showrollover="false">Dostarlimab</span> for Primary Advanced or Recurrent Endometrial Cancer. <i>N Engl J Med</i> 388(23):2145-2158, 2023. doi:10.1056/NEJMoa2216334</p></div></li><li class="topic__listitem"><span id="v84058294" class="anchor"></span><div class="para"> <p>11. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36972022/">Eskander RN, Sill MW, Beffa L, et al</a>: <span class="genericDrug" data-showrollover="false">Pembrolizumab</span> plus Chemotherapy in Advanced Endometrial Cancer. <i>N Engl J Med</i> 388(23):2159-2170, 2023. doi:10.1056/NEJMoa2302312</p></div></li><li class="topic__listitem"><span id="v68352342" class="anchor"></span><div class="para"> <p>12. <a rel="nofollow" target="_blank" href="https://www.ajog.org/article/S0002-9378(20)30861-9/fulltext">Westin SN, Fellman B, Sun CC, et al</a>: Prospective phase II trial of <span class="genericDrug" data-showrollover="false">levonorgestrel</span> intrauterine device: Nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. <i>Am J Obstet Gynecol</i> 224 (2):191.e1-191.e15, 2021. doi: 10.1016/j.ajog.2020.08.032 </p></div></li></ul></div> </div> </section> </div> </section> <section id="v1066999" class="topic__section FHead"> <h2 id="Prognosis_v1067000" class="topic__header--section" data-originaltitle="Prognosis"> <span id="v1067000" class="anchor"></span> Prognosis for Endometrial Cancer </h2> <div class="topic__content"> <span id="v1067001" class="anchor"></span><div class="para"> <p>Prognosis is worse with higher-grade tumors, more extensive spread, and older patient age.</p></div><span id="v31322630" class="anchor"></span><div class="para"> <p>Average 5-year survival rates for patients with endometrial cancer are (<a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058300" data-toggle="tooltip" title="Prognosis reference" data-id="5d2ff38a-507e-420e-b227-988c82a70eeb" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">1</a><span id="5d2ff38a-507e-420e-b227-988c82a70eeb" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html#v84058300"> <span class="tooltip-content"> <span class="tooltip-heading"> Prognosis reference </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>)</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8544474" class="anchor"></span><div class="para"> <p>Stage I or II: 70 to 95%</p></div></li><li class="topic__listitem"><span id="v8544476" class="anchor"></span><div class="para"> <p>Stage III or IV: 10 to 60%</p></div></li></ul></div><span id="v8544477" class="anchor"></span><div class="para"> <p>Overall, 63% of patients are cancer-free <span class='symbol'>≥</span> 5 years after treatment.</p></div> <section id="v84058299" class="topic__section GHead"> <span></span> <h3 id="Prognosis_v1067000_v84058300" class="topic__header--subsection"> <span id="v84058300" class="anchor"></span> Prognosis reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84058303" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://seer.cancer.gov/statfacts/html/corp.html">National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program</a>: Cancer Stat Facts: Uterine Cancer. Accessed August 31, 2023</p></div></li></ul></div> </div> </section> </div> </section> <section id="v8544478" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v8544479" class="topic__header--section"> <span id="v8544479" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8544482" class="anchor"></span><div class="para"> <p>Endometrial cancer is one of the most common cancers among women.</p></div></li><li class="topic__listitem"><span id="v8544484" class="anchor"></span><div class="para"> <p>Prognosis is better with type I tumors, which are grade 1 or 2 endometrioid adenocarcinomas; they tend to be <span class="genericDrug" data-showrollover="false">estrogen</span>-responsive and diagnosed at a younger age.</p></div></li><li class="topic__listitem"><span id="v8544486" class="anchor"></span><div class="para"> <p>Recommend endometrial sampling for women with abnormal uterine bleeding, particularly those > 45 years; ultrasound assessment of endometrial thickness is an alternative for average-risk postmenopausal women.</p></div></li><li class="topic__listitem"><span id="v8544488" class="anchor"></span><div class="para"> <p>Stage endometrial cancer surgically via laparotomy, laparoscopy, or a robotic-assisted surgery.</p></div></li><li class="topic__listitem"><span id="v8544490" class="anchor"></span><div class="para"> <p>Treatment is usually total hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy and sometimes radiation therapy and/or chemotherapy.</p></div></li><li class="topic__listitem"><span id="v31322692" class="anchor"></span><div class="para"> <p>Consider sentinel lymph node mapping for cancers that appear to be confined to the uterus.</p></div></li><li class="topic__listitem"><span id="v31322694" class="anchor"></span><div class="para"> <p>Consider fertility-sparing treatment for patients with grade 1 endometrioid adenocarcinoma or endometrial complex atypical hyperplasia.</p></div></li><li class="topic__listitem"><span id="v31322696" class="anchor"></span><div class="para"> <p>Consider genetic counseling and testing for patients < 50 years and those with a significant family history of endometrial, ovarian, and/or colorectal cancer (Lynch syndrome [hereditary nonpolyposis colorectal cancer]). </p></div></li></ul></div> </div> </section> <section id="v31322697" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v31322698" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v49777980" class="anchor"></span><div class="para"> <p>The following English-language resource may be useful. Please note that THE MANUAL is not responsible for the content of this resource.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v31322701" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.cancer.gov/types/uterine/hp/endometrial-treatment-pdq">National Cancer Institute: Endometrial Cancer Treatment</a>: This web site provides information about endometrial cancer, its classification, staging, and treatment by stage.</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="182.0;198.82;233.2">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '182.0;198.82;233.2',
 title: 'Endometrial Cancer',
 itemGuid: 'b70abee6-7ee0-4ca4-bbc4-d37298f9a946'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{0F702974-0A2D-4CA5-8490-11E2730A661C}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Vaginal Cancer</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{AB141F77-EA01-4252-8A4D-A5D08C7A13C7}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Uterine Sarcomas</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="f3c4e532-5973-4a59-add1-b615d777a24c_mobile" usemap="#f3c4e532-5973-4a59-add1-b615d777a24c_mobile" width="326" height="90">
 <map name="f3c4e532-5973-4a59-add1-b615d777a24c_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="f3c4e532-5973-4a59-add1-b615d777a24c_tablet" usemap="#f3c4e532-5973-4a59-add1-b615d777a24c_tablet" width="326" height="90">
 <map name="f3c4e532-5973-4a59-add1-b615d777a24c_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="f3c4e532-5973-4a59-add1-b615d777a24c_desktop" usemap="#f3c4e532-5973-4a59-add1-b615d777a24c_desktop" width="326" height="90">
 <map name="f3c4e532-5973-4a59-add1-b615d777a24c_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd02
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="B70ABEE67EE04CA4BBC4D37298F9A946">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v1066908'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1066910"></span> <div class="TableFullPage" id="v1066908"> <h3 class="title">FIGO Staging of Uterine Corpus Carcinoma and Carcinosarcoma</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1257192" class="anchor"></span><div class="para"> <p>Stage*</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1257195" class="anchor"></span><div class="para"> <p>Definition</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v1066920" class="anchor"></span><div class="para"> <p>I†</p></div></td><td><span id="v1066922" class="anchor"></span><div class="para"> <p>Confined to the uterine corpus and ovaryǂ</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291250" class="anchor"></span><div class="para"> <p>IA</p></div></li></ul></div></td><td><span id="v1066927" class="anchor"></span><div class="para"> <p>Disease limited to the endometrium OR non-aggressive histologic type#, with invasion of less than half of myometrium with no or focal lymphovascular space involvement (LVSI)§ OR good prognosis disease</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150544" class="anchor"></span><div class="para"> <p>IA1</p></div></li></ul></div></td><td><span id="v84150546" class="anchor"></span><div class="para"> <p>Non-aggressive histologic type limited to an endometrial polyp OR confined to the endometrium</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150596" class="anchor"></span><div class="para"> <p>IA2</p></div></li></ul></div></td><td><span id="v84150598" class="anchor"></span><div class="para"> <p>Non-aggressive histologic type involving less than half of the myometrium with no or focal LVSI</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150627" class="anchor"></span><div class="para"> <p>IA3</p></div></li></ul></div></td><td><span id="v84150629" class="anchor"></span><div class="para"> <p>Low-grade endometrioid endometrial carcinomas (EECs) limited to the uterus and ovaryǂ</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291253" class="anchor"></span><div class="para"> <p>IB</p></div></li></ul></div></td><td><span id="v1066932" class="anchor"></span><div class="para"> <p>Non-aggressive histologic types# with invasion of half or more of the myometrium, and with no or focal LVSI§</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150671" class="anchor"></span><div class="para"> <p>IC</p></div></li></ul></div></td><td><span id="v84150673" class="anchor"></span><div class="para"> <p>Aggressive histologic types# limited to a polyp or confined to the endometrium</p></div></td></tr><tr class="even"><td><span id="v1066940" class="anchor"></span><div class="para"> <p>II†</p></div></td><td><span id="v1066942" class="anchor"></span><div class="para"> <p>Invasion of the cervical stroma without extension outside the uterus OR with substantial LVSI OR aggressive histologic types with myometrial invasion</p></div></td></tr><tr class="odd"><td><span id="v84150723" class="anchor"></span><div class="para"> <p>IIA</p></div></td><td><span id="v84150725" class="anchor"></span><div class="para"> <p>Invasion of the cervical stroma of non-aggressive histologic types</p></div></td></tr><tr class="even"><td><span id="v84150773" class="anchor"></span><div class="para"> <p>IIB</p></div></td><td><span id="v84150775" class="anchor"></span><div class="para"> <p>Substantial LVSI§ of non-aggressive histologic types</p></div></td></tr><tr class="odd"><td><span id="v84150804" class="anchor"></span><div class="para"> <p>IIC</p></div></td><td><span id="v84150806" class="anchor"></span><div class="para"> <p>Aggressive histologic types with any myometrial involvement</p></div></td></tr><tr class="even"><td><span id="v1066955" class="anchor"></span><div class="para"> <p>III</p></div></td><td><span id="v1066957" class="anchor"></span><div class="para"> <p>Local and/or regional spread of the tumor of any histologic subtype</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291256" class="anchor"></span><div class="para"> <p>IIIA</p></div></li></ul></div></td><td><span id="v1066962" class="anchor"></span><div class="para"> <p>Invasion of uterine serosa, adnexa, or both (direct extension or metastasis)</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150864" class="anchor"></span><div class="para"> <p>IIIA1</p></div></li></ul></div></td><td><span id="v84150866" class="anchor"></span><div class="para"> <p>Spread to ovary or fallopian tube (except when meeting stage IA3 criteria)ǂ </p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151239" class="anchor"></span><div class="para"> <p>IIIA2</p></div></li></ul></div></td><td><span id="v84151241" class="anchor"></span><div class="para"> <p>Involvement of uterine subserosa or spread through the uterine serosa</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291259" class="anchor"></span><div class="para"> <p>IIIB</p></div></li></ul></div></td><td><span id="v1066967" class="anchor"></span><div class="para"> <p>Metastasis or direct spread to the vagina and/or spread to the parametria or pelvic peritoneum</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151290" class="anchor"></span><div class="para"> <p>IIIB1</p></div></li></ul></div></td><td><span id="v84151292" class="anchor"></span><div class="para"> <p>Metastasis or direct spread to the vagina and/or the parametria</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151318" class="anchor"></span><div class="para"> <p>IIIB2</p></div></li></ul></div></td><td><span id="v84151320" class="anchor"></span><div class="para"> <p>Metastasis to the pelvic peritoneum</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291262" class="anchor"></span><div class="para"> <p>IIIC</p></div></li></ul></div></td><td><span id="v1066972" class="anchor"></span><div class="para"> <p>Metastases to pelvic or para-aortic lymph nodes or to both¶</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291265" class="anchor"></span><div class="para"> <p>IIIC1</p></div></li></ul></div></td><td><span id="v8544466" class="anchor"></span><div class="para"> <p>Metastases to pelvic lymph nodes</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151349" class="anchor"></span><div class="para"> <p>IIIC1i</p></div></li></ul></div></td><td><span id="v84151351" class="anchor"></span><div class="para"> <p>Micrometastasis</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151383" class="anchor"></span><div class="para"> <p>IIIC1ii</p></div></li></ul></div></td><td><span id="v84151385" class="anchor"></span><div class="para"> <p>Macrometastasis</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291268" class="anchor"></span><div class="para"> <p>IIIC2</p></div></li></ul></div></td><td><span id="v8544471" class="anchor"></span><div class="para"> <p>Metastasis to para-aortic lymph nodes up to the renal vessels, with or without metastasis to the pelvic lymph nodes</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151445" class="anchor"></span><div class="para"> <p>IIIC2i</p></div></li></ul></div></td><td><span id="v84151447" class="anchor"></span><div class="para"> <p>Micrometastasis</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151481" class="anchor"></span><div class="para"> <p>IIIC2i</p></div></li></ul></div></td><td><span id="v84151483" class="anchor"></span><div class="para"> <p>Macrometastasis</p></div></td></tr><tr class="even"><td><span id="v1066975" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v1066977" class="anchor"></span><div class="para"> <p>Spread to the bladder and/or intestinal mucosa and/or distant metastasis </p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291271" class="anchor"></span><div class="para"> <p>IVA</p></div></li></ul></div></td><td><span id="v1066982" class="anchor"></span><div class="para"> <p>Invasion of the bladder, intestinal mucosa, or both</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291274" class="anchor"></span><div class="para"> <p>IVB</p></div></li></ul></div></td><td><span id="v1066987" class="anchor"></span><div class="para"> <p>Abdominal peritoneal metastasis beyond the pelvis</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151529" class="anchor"></span><div class="para"> <p>IVC</p></div></li></ul></div></td><td><span id="v84151531" class="anchor"></span><div class="para"> <p>Distant metastasis, including metastasis to any extra- or intra-abdominal lymph nodes above the renal vessels, lungs, liver, brain, or bone</p></div></td></tr><tr class="even" tablehead1=""><td><p class="tableHead1"><span id="v84151912" class="anchor"></span><div class="para"> <p>Endometrial cancer stage with molecular classification (examples)</p></div></p></td><td><p class="tableHead1"><span id="v84151915" class="anchor"></span><div class="para"> <p></div></p></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84152022" class="anchor"></span><div class="para"> <p>Stage designation</p></div></li></ul></div></td><td><span id="v84152024" class="anchor"></span><div class="para"> <p>Molecular findings in patients with early endometrial cancer (Stages I and II after surgical staging)</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84152049" class="anchor"></span><div class="para"> <p>Stage IAm</p></div></li></ul></div></td><td><span id="v84152051" class="anchor"></span><div class="para"> <p><i data-mmanualobjecttype='gene' '>POLEmut</i> endometrial carcinoma, confined to the uterine corpus or with cervical extension, regardless of the degree of LVSI or histological type </p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84152079" class="anchor"></span><div class="para"> <p>Stage IICm</p></div></li></ul></div></td><td><span id="v84152081" class="anchor"></span><div class="para"> <p>p53abn endometrial carcinoma confined to the uterine corpus with any myometrial invasion, with or without cervical invasion, and regardless of the degree of LVSI or histological type </p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v1066994" class="anchor"></span><div class="para"> <p>* In all stages, the grade of the lesion, the histologic type, and LVSI must be recorded.</p></div></td></tr><tr><td colspan="2"><span id="v68351151" class="anchor"></span><div class="para"> <p>† If available and feasible, molecular classification testing (<i data-mmanualobjecttype='gene' '>POLEmut</i>, MMRd, NSMP, p53abn) is encouraged in all patients with endometrial cancer for prognostic risk-group stratification and as factors that might influence adjuvant and systemic treatment decisions.</p></div></td></tr><tr><td colspan="2"><span id="v68351154" class="anchor"></span><div class="para"> <p>‡ Low-grade endometrioid endometrial carcinomas (EECs) involving both the endometrium and the ovary are considered to have a good prognosis, and no adjuvant treatment is recommended, only if all criteria are met to distinguish disease limited to low-grade endometrioid carcinomas involving the endometrium and ovaries (Stage IA3) from extensive spread of the endometrial carcinoma to the ovary (Stage IIIA1). These criteria are: (1) no more than superficial myometrial invasion is present (<span class='symbol'></span> 50%); (2) absence of extensive/substantial LVSI; (3) absence of additional metastases; and (4) the ovarian tumor is unilateral, limited to the ovary, without capsule invasion/rupture.</p></div></td></tr><tr><td colspan="2"><span id="v84151707" class="anchor"></span><div class="para"> <p># Non-aggressive histologic types are composed of low-grade (grade 1 and 2) EECs. Aggressive histologic types are composed of high-grade EECs (grade 3), serous, clear cell, undifferentiated, mixed, mesonephric-like, gastrointestinal mucinous type carcinomas, and carcinosarcomas.</p></div></td></tr><tr><td colspan="2"><span id="v84151724" class="anchor"></span><div class="para"> <p>§ LVSI as defined as extensive/substantial, ≥ 5 vessels involved.</p></div></td></tr><tr><td colspan="2"><span id="v84151740" class="anchor"></span><div class="para"> <p>¶ Micrometastases are considered to be metastatic involvement (pN1 (mi)). The prognostic significance of isolated tumor cells (ITCs) is unclear. The presence of ITCs should be documented and is regarded as pN0(i+). According to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 8th ed, macrometastases are > 2 mm in size, micrometastases are 0.2–2 mm and/or > 200 cells, and isolated tumor cells are ≥ 0.2 mm and ≤ 200 cells.</p></div></td></tr><tr><td colspan="2"><span id="v8544460" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.14923">Berek JS, Matias-Guiu X, Creutzberg C, et al</a>: FIGO staging of endometrial cancer: 2023. <i>Int J Gynaecol Obstet</i> 2023;162(2):383-394. doi:10.1002/ijgo.14923</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v1066908'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1066910"></span> <div class="TableFullPage" id="v1066908"> <h3 class="title">FIGO Staging of Uterine Corpus Carcinoma and Carcinosarcoma</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1257192" class="anchor"></span><div class="para"> <p>Stage*</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1257195" class="anchor"></span><div class="para"> <p>Definition</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v1066920" class="anchor"></span><div class="para"> <p>I†</p></div></td><td><span id="v1066922" class="anchor"></span><div class="para"> <p>Confined to the uterine corpus and ovaryǂ</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291250" class="anchor"></span><div class="para"> <p>IA</p></div></li></ul></div></td><td><span id="v1066927" class="anchor"></span><div class="para"> <p>Disease limited to the endometrium OR non-aggressive histologic type#, with invasion of less than half of myometrium with no or focal lymphovascular space involvement (LVSI)§ OR good prognosis disease</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150544" class="anchor"></span><div class="para"> <p>IA1</p></div></li></ul></div></td><td><span id="v84150546" class="anchor"></span><div class="para"> <p>Non-aggressive histologic type limited to an endometrial polyp OR confined to the endometrium</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150596" class="anchor"></span><div class="para"> <p>IA2</p></div></li></ul></div></td><td><span id="v84150598" class="anchor"></span><div class="para"> <p>Non-aggressive histologic type involving less than half of the myometrium with no or focal LVSI</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150627" class="anchor"></span><div class="para"> <p>IA3</p></div></li></ul></div></td><td><span id="v84150629" class="anchor"></span><div class="para"> <p>Low-grade endometrioid endometrial carcinomas (EECs) limited to the uterus and ovaryǂ</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291253" class="anchor"></span><div class="para"> <p>IB</p></div></li></ul></div></td><td><span id="v1066932" class="anchor"></span><div class="para"> <p>Non-aggressive histologic types# with invasion of half or more of the myometrium, and with no or focal LVSI§</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150671" class="anchor"></span><div class="para"> <p>IC</p></div></li></ul></div></td><td><span id="v84150673" class="anchor"></span><div class="para"> <p>Aggressive histologic types# limited to a polyp or confined to the endometrium</p></div></td></tr><tr class="even"><td><span id="v1066940" class="anchor"></span><div class="para"> <p>II†</p></div></td><td><span id="v1066942" class="anchor"></span><div class="para"> <p>Invasion of the cervical stroma without extension outside the uterus OR with substantial LVSI OR aggressive histologic types with myometrial invasion</p></div></td></tr><tr class="odd"><td><span id="v84150723" class="anchor"></span><div class="para"> <p>IIA</p></div></td><td><span id="v84150725" class="anchor"></span><div class="para"> <p>Invasion of the cervical stroma of non-aggressive histologic types</p></div></td></tr><tr class="even"><td><span id="v84150773" class="anchor"></span><div class="para"> <p>IIB</p></div></td><td><span id="v84150775" class="anchor"></span><div class="para"> <p>Substantial LVSI§ of non-aggressive histologic types</p></div></td></tr><tr class="odd"><td><span id="v84150804" class="anchor"></span><div class="para"> <p>IIC</p></div></td><td><span id="v84150806" class="anchor"></span><div class="para"> <p>Aggressive histologic types with any myometrial involvement</p></div></td></tr><tr class="even"><td><span id="v1066955" class="anchor"></span><div class="para"> <p>III</p></div></td><td><span id="v1066957" class="anchor"></span><div class="para"> <p>Local and/or regional spread of the tumor of any histologic subtype</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291256" class="anchor"></span><div class="para"> <p>IIIA</p></div></li></ul></div></td><td><span id="v1066962" class="anchor"></span><div class="para"> <p>Invasion of uterine serosa, adnexa, or both (direct extension or metastasis)</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84150864" class="anchor"></span><div class="para"> <p>IIIA1</p></div></li></ul></div></td><td><span id="v84150866" class="anchor"></span><div class="para"> <p>Spread to ovary or fallopian tube (except when meeting stage IA3 criteria)ǂ </p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151239" class="anchor"></span><div class="para"> <p>IIIA2</p></div></li></ul></div></td><td><span id="v84151241" class="anchor"></span><div class="para"> <p>Involvement of uterine subserosa or spread through the uterine serosa</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291259" class="anchor"></span><div class="para"> <p>IIIB</p></div></li></ul></div></td><td><span id="v1066967" class="anchor"></span><div class="para"> <p>Metastasis or direct spread to the vagina and/or spread to the parametria or pelvic peritoneum</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151290" class="anchor"></span><div class="para"> <p>IIIB1</p></div></li></ul></div></td><td><span id="v84151292" class="anchor"></span><div class="para"> <p>Metastasis or direct spread to the vagina and/or the parametria</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151318" class="anchor"></span><div class="para"> <p>IIIB2</p></div></li></ul></div></td><td><span id="v84151320" class="anchor"></span><div class="para"> <p>Metastasis to the pelvic peritoneum</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291262" class="anchor"></span><div class="para"> <p>IIIC</p></div></li></ul></div></td><td><span id="v1066972" class="anchor"></span><div class="para"> <p>Metastases to pelvic or para-aortic lymph nodes or to both¶</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291265" class="anchor"></span><div class="para"> <p>IIIC1</p></div></li></ul></div></td><td><span id="v8544466" class="anchor"></span><div class="para"> <p>Metastases to pelvic lymph nodes</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151349" class="anchor"></span><div class="para"> <p>IIIC1i</p></div></li></ul></div></td><td><span id="v84151351" class="anchor"></span><div class="para"> <p>Micrometastasis</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151383" class="anchor"></span><div class="para"> <p>IIIC1ii</p></div></li></ul></div></td><td><span id="v84151385" class="anchor"></span><div class="para"> <p>Macrometastasis</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291268" class="anchor"></span><div class="para"> <p>IIIC2</p></div></li></ul></div></td><td><span id="v8544471" class="anchor"></span><div class="para"> <p>Metastasis to para-aortic lymph nodes up to the renal vessels, with or without metastasis to the pelvic lymph nodes</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151445" class="anchor"></span><div class="para"> <p>IIIC2i</p></div></li></ul></div></td><td><span id="v84151447" class="anchor"></span><div class="para"> <p>Micrometastasis</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151481" class="anchor"></span><div class="para"> <p>IIIC2i</p></div></li></ul></div></td><td><span id="v84151483" class="anchor"></span><div class="para"> <p>Macrometastasis</p></div></td></tr><tr class="even"><td><span id="v1066975" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v1066977" class="anchor"></span><div class="para"> <p>Spread to the bladder and/or intestinal mucosa and/or distant metastasis </p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291271" class="anchor"></span><div class="para"> <p>IVA</p></div></li></ul></div></td><td><span id="v1066982" class="anchor"></span><div class="para"> <p>Invasion of the bladder, intestinal mucosa, or both</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291274" class="anchor"></span><div class="para"> <p>IVB</p></div></li></ul></div></td><td><span id="v1066987" class="anchor"></span><div class="para"> <p>Abdominal peritoneal metastasis beyond the pelvis</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84151529" class="anchor"></span><div class="para"> <p>IVC</p></div></li></ul></div></td><td><span id="v84151531" class="anchor"></span><div class="para"> <p>Distant metastasis, including metastasis to any extra- or intra-abdominal lymph nodes above the renal vessels, lungs, liver, brain, or bone</p></div></td></tr><tr class="even" tablehead1=""><td><p class="tableHead1"><span id="v84151912" class="anchor"></span><div class="para"> <p>Endometrial cancer stage with molecular classification (examples)</p></div></p></td><td><p class="tableHead1"><span id="v84151915" class="anchor"></span><div class="para"> <p></div></p></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84152022" class="anchor"></span><div class="para"> <p>Stage designation</p></div></li></ul></div></td><td><span id="v84152024" class="anchor"></span><div class="para"> <p>Molecular findings in patients with early endometrial cancer (Stages I and II after surgical staging)</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84152049" class="anchor"></span><div class="para"> <p>Stage IAm</p></div></li></ul></div></td><td><span id="v84152051" class="anchor"></span><div class="para"> <p><i data-mmanualobjecttype='gene' '="">POLEmut</i> endometrial carcinoma, confined to the uterine corpus or with cervical extension, regardless of the degree of LVSI or histological type </p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84152079" class="anchor"></span><div class="para"> <p>Stage IICm</p></div></li></ul></div></td><td><span id="v84152081" class="anchor"></span><div class="para"> <p>p53abn endometrial carcinoma confined to the uterine corpus with any myometrial invasion, with or without cervical invasion, and regardless of the degree of LVSI or histological type </p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v1066994" class="anchor"></span><div class="para"> <p>* In all stages, the grade of the lesion, the histologic type, and LVSI must be recorded.</p></div></td></tr><tr><td colspan="2"><span id="v68351151" class="anchor"></span><div class="para"> <p>† If available and feasible, molecular classification testing (<i data-mmanualobjecttype='gene' '="">POLEmut</i>, MMRd, NSMP, p53abn) is encouraged in all patients with endometrial cancer for prognostic risk-group stratification and as factors that might influence adjuvant and systemic treatment decisions.</p></div></td></tr><tr><td colspan="2"><span id="v68351154" class="anchor"></span><div class="para"> <p>‡ Low-grade endometrioid endometrial carcinomas (EECs) involving both the endometrium and the ovary are considered to have a good prognosis, and no adjuvant treatment is recommended, only if all criteria are met to distinguish disease limited to low-grade endometrioid carcinomas involving the endometrium and ovaries (Stage IA3) from extensive spread of the endometrial carcinoma to the ovary (Stage IIIA1). These criteria are: (1) no more than superficial myometrial invasion is present (<span class='symbol'></span> 50%); (2) absence of extensive/substantial LVSI; (3) absence of additional metastases; and (4) the ovarian tumor is unilateral, limited to the ovary, without capsule invasion/rupture.</p></div></td></tr><tr><td colspan="2"><span id="v84151707" class="anchor"></span><div class="para"> <p># Non-aggressive histologic types are composed of low-grade (grade 1 and 2) EECs. Aggressive histologic types are composed of high-grade EECs (grade 3), serous, clear cell, undifferentiated, mixed, mesonephric-like, gastrointestinal mucinous type carcinomas, and carcinosarcomas.</p></div></td></tr><tr><td colspan="2"><span id="v84151724" class="anchor"></span><div class="para"> <p>§ LVSI as defined as extensive/substantial, ≥ 5 vessels involved.</p></div></td></tr><tr><td colspan="2"><span id="v84151740" class="anchor"></span><div class="para"> <p>¶ Micrometastases are considered to be metastatic involvement (pN1 (mi)). The prognostic significance of isolated tumor cells (ITCs) is unclear. The presence of ITCs should be documented and is regarded as pN0(i+). According to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 8th ed, macrometastases are > 2 mm in size, micrometastases are 0.2–2 mm and/or > 200 cells, and isolated tumor cells are ≥ 0.2 mm and ≤ 200 cells.</p></div></td></tr><tr><td colspan="2"><span id="v8544460" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.14923">Berek JS, Matias-Guiu X, Creutzberg C, et al</a>: FIGO staging of endometrial cancer: 2023. <i>Int J Gynaecol Obstet</i> 2023;162(2):383-394. doi:10.1002/ijgo.14923</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>